drugset / Trial / NCT05484856

Evaluation of Clinical Efficacy of Autologous Adipose Tissue Derived ADSCSs in Treatment of Osteoarthritis (OA)

NCT05484856 ↗

Phase 1/2 Completed 140 enrolled Dr. Himanshu Bansal Foundation
NaSingle-groupOpen-labelTreatment

Summary

Osteoarthritis (OA) is a degenerative disease of great morbidity in which therapies are typically palliative and only alleviate pain Mesenchymal stem cells ,adipose derived stromal cell are possible new chondroprotective regenerative treatment modalities. Clinical Effectiveness after administration of adipose derived stromal cells along with platelet rich plasma was investigated in 140 patients having moderate to severe knee (stage 3 and 4) Patients were evaluated and followed up for 2 year by subjective WOMAC score,six minute walking distance ,need of rescue medication Radiographic and MRI evaluation of joint space and cartilage thickness respectively

Timeline

Start
2016-05-16
Primary completion
2020-06-27
Completion
2021-02-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous adipose tissue derived stromal cells Unknown — —

Indications